Ciclopirox and Ocular hyperaemia - a phase IV clinical study of FDA data

Summary:

Ocular hyperaemia is reported as a side effect among people who take Ciclopirox (ciclopirox), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Dermatitis.

The phase IV clinical study analyzes which people have Ocular hyperaemia when taking Ciclopirox. It is created by eHealthMe based on reports of 2,627 people who have side effects when taking Ciclopirox from the FDA, and is updated regularly.

What is Ciclopirox?

Ciclopirox has active ingredients of ciclopirox. eHealthMe is studying from 2,646 Ciclopirox users. Check the latest studies of Ciclopirox.

What is Ocular hyperaemia?

Ocular hyperaemia (an abnormally large amount of blood in eye) is found to be associated with 1,355 drugs and 1,500 conditions by eHealthMe. Check the latest studies of Ocular hyperaemia.

On Jul, 29, 2026

2,627 people reported to have side effects when taking Ciclopirox.
Among them, 13 people (0.49%) have Ocular hyperaemia.

Could Ciclopirox cause Ocular hyperaemia?

Among these 13 people:

How long have people been on Ciclopirox when they have Ocular hyperaemia? *

What is the gender of people who have Ocular hyperaemia when taking Ciclopirox? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Ocular hyperaemia when taking Ciclopirox? *

What are other drugs people take besides Ciclopirox? *

What are other side effects people have besides Ocular hyperaemia? *

Eye Irritation: 5 people, 38.46%
Eye Pruritus (eye itching): 4 people, 30.77%
Eye Swelling: 4 people, 30.77%
Fatigue (feeling of tiredness): 4 people, 30.77%
Vision Blurred: 3 people, 23.08%
Lacrimation Increased: 3 people, 23.08%
Back Pain: 3 people, 23.08%
Drug Ineffective: 3 people, 23.08%
Diarrhea: 3 people, 23.08%
Depression: 3 people, 23.08%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 2 people, 15.38%
Multiple Myeloma (cancer of the plasma cells): 2 people, 15.38%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 15.38%
Nail Discoloration: 1 person, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 7.69%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.69%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 7.69%
Fungal Infection: 1 person, 7.69%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ciclopirox and have Ocular hyperaemia?

- Check whether Ocular hyperaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ciclopirox:

Ciclopirox (2,646 reports)

Browse all side effects of Ciclopirox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,355 drugs)

Browse all the conditions that are associated with Ocular hyperaemia:

Ocular hyperaemia (1,500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox (the active ingredients of Ciclopirox) and Ciclopirox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.